Gilead Sciences Inc (GILD) is a renowned biopharmaceutical company with a strong presence in the global healthcare market. This article focuses on the technical analysis of GILD stock using various indicators. Technical analysis helps traders and investors make informed decisions by analyzing historical price and volume data. By studying various technical indicators, one can gain insights into a stock's trend, momentum, and potential reversal points.

One of the key technical indicators used in analyzing GILD stock is the Relative Strength Index (RSI). RSI measures the strength and speed of price movements and ranges from 0 to 100. It helps identify overbought and oversold levels. Another important indicator is the Average Directional Index (ADX), which determines the strength of a stock's trend. ADX readings above 25 indicate a strong trend.

Gilead Sciences  (GILD) Technical Analysis

Learn about the technical analysis of Gilead Sciences Inc (GILD) stock. Find out the stock's RSI, ADX, MACD, ROC, STOCHRSI, and WILLR indicators. Understand the current and potential future performance of Gilead Sciences Inc using technical analysis.

Gilead Sciences Inc (GILD) Technical Analysis: Stock Indicators, RSI, ADX, MACD, ROC, STOCHRSI, WILLR

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Gilead Sciences 

NASDAQ

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Balanced or Uncertain

MACD

WILLR

STOCHRSI

Free

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

Name	Value	Action	infoPnL (10y)
auto_graphRSI	61.52	Neutral	22.7%
auto_graphMACD	20.90	Neutral	205.0%
auto_graphCCI	83.89	Neutral	59.5%
auto_graphADX	31.97	Neutral	-
auto_graphATR	20.32	Buy	-
auto_graphWILLR	-29.43	Neutral	156.7%
auto_graphROC	33.53	Neutral	201.9%
auto_graphSTOCHRSI	0.00	Buy	-99.4%

Buy	2	-75.00%
Hold	6	-25.00%
Sell	0	-100.00%

Trendlines, Support and Resistance

Welcome to Stocklytics

Technical Indicators

Indicator Ratings

Balanced or Uncertain

Gilead Sciences (GILD) Technical Analysis

Keep an eye on Gilead Sciences

Frequently Asked Questions

What are the technical signals for Gilead Sciences (GILD) stock based on the last 30 days?

Take Your Investments to a Whole New Level